Continuous Manufacturing Research Act of 2021

Bill: 117-hr-3851
Sponsor: full_name: Rep. Spanberger, Abigail Davis [D-VA-7]
Introduced: 2021-06-11
Policy area: Science, Technology, Communications
Latest action: action_date: 2021-06-11
text: Referred to the House Committee on Science, Space, and Technology.

Summaries:
action_date: 2021-06-11
action_desc: Introduced in House
text: <p><strong>Continuous Manufacturing Research Act of 2021</strong></p> <p>This bill adds advanced pharmaceutical manufacturing as a research area that may be supported under the National Science Foundation's manufacturing research grant program.</p>

tv_txt: I 117th CONGRESS 1st Session H. R. 3851 IN THE HOUSE OF REPRESENTATIVES June 11, 2021 Ms. Spanberger (for herself, Mr. Gonzalez of Ohio , Mr. Meijer , Ms. Ross , Mr. Tonko , and Mr. McKinley ) introduced the following bill; which was referred to the Committee on Science, Space, and Technology A BILL To improve support for research and development of advanced pharmaceutical manufacturing techniques and workforce.

1. Short title This Act may be cited as the Continuous Manufacturing Research Act of 2021 . 2. Research on advanced pharmaceutical manufacturing Section 506(a) of the America COMPETES Reauthorization Act of 2010 ( 42 U.S.C. 1862p–1(a) ) is amended— (1) in paragraph (5), by striking and at the end; (2) in paragraph (6), by striking the period at the end and inserting ; and ; and (3) by adding at the end the following: (7) advanced pharmaceutical manufacturing fundamental and translational research, including— (A) continuous manufacturing of drugs and biological products; and (B) similar innovative monitoring and control techniques. .